News

Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...
Telehealth platform Hims & Hers is set to acquire UK startup Zava to strengthen its international presence. Meanwhile, ...
Still, several growth stocks have delivered jaw-dropping returns this year. These two innovation stocks are primed for ...
Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...
Tuesday, online health and wellness company Hims & Hers announced its intent to acquire European digital healthcare provider ...
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
Telehealth platform Hims & Hers said on Tuesday it will acquire London-based startup Zava for an undisclosed amount, allowing it to launch its offerings in Germany, France and Ireland and reach more ...
The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.
The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...
Skyline view of the City of London financial district from the viewpoint in Greenwich Park in London, United Kingdom. This is ...
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...